Skip to main content
Addgene

pCH043
(Plasmid #47949)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 47949 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pRS306
  • Backbone manufacturer
    ATCC
  • Total vector size (bp) 4373
  • Vector type
    Yeast Expression ; Tet inducible expression
  • Selectable markers
    URA3

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Low Copy

Gene/Insert

  • Gene/Insert name
    rtTA
  • Promoter Gal1

Cloning Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

TetR is downstream of Gal1 promoter.

The expression in these constructs is driven by tet operators. The GAL1 promoter contains a mutation in the proximal Gal4 BS to have only three Gal4 binding sites. Since the above plasmids (pCH043, pSS63, pPR184) can be used only in delGal4 strains, this does not affect the basal expression in these constructs.

The discrepancies found between the Addgene QC sequence and the full sequence do not affect the functioning of the construct.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCH043 was a gift from Attila Becskei (Addgene plasmid # 47949 ; http://n2t.net/addgene:47949 ; RRID:Addgene_47949)
  • For your References section:

    Stochastic signalling rewires the interaction map of a multiple feedback network during yeast evolution. Hsu C, Scherrer S, Buetti-Dinh A, Ratna P, Pizzolato J, Jaquet V, Becskei A. Nat Commun. 2012 Feb 21;3:682. doi: 10.1038/ncomms1687. 10.1038/ncomms1687 PubMed 22353713